Chemical compounds identified by in silico molecular modelling, and having an structure that allows the blocking of the phosphorylation event, through the interaction of such compounds with the phosphorylation domain or its milieu in the substrates of the Casein Kinase 2 enzyme. This invention comprises also the pharmaceutical compositions containing such compounds, and their use in the preparation of medicines for the treatment of diseases related with neoplasic processes.
通过
硅学分子建模确定的化合物,其结构可通过与
酪蛋白激酶 2 酶底物中的
磷酸化结构域或其环境相互作用,阻断
磷酸化过程。本发明还包括含有此类化合物的药物组合物,以及它们在制备治疗与肿瘤过程有关的疾病的药物中的用途。